Drug intelligence / Profile preview

Sudin Cold

Development stage
Unknown
Lead developer
Group Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Sudin Cold is an over-the-counter (OTC) combination pharmaceutical product developed and marketed by Group Pharmaceutical. It is formulated as an anti-cold tablet intended for the symptomatic relief of the common cold, influenza, and allergic rhinitis. The medication typically contains a combination of three active ingredients: paracetamol (acetaminophen), phenylephrine hydrochloride, and chlorpheniramine maleate. Paracetamol serves as an analgesic and antipyretic by inhibiting prostaglandin synthesis in the central nervous system. Phenylephrine acts as a nasal decongestant through selective alpha-1 adrenergic receptor agonism, leading to vasoconstriction in the nasal passages. Chlorpheniramine maleate is a first-generation antihistamine that antagonizes H1 receptors to alleviate symptoms such as sneezing, rhinorrhea, and itchy/watery eyes.

Brand names
Sudin Cold
02

Targets

ADRA1A (α1A)HRH1 (Histamine H1 Receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Sudin Cold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sudin Cold.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call